Related Experiment Videos
[National program for neonatal screening for cystic fibrosis: implementation and preliminary results]
J Navarro1, C Grosskopf, M Vidailhet
1Hôpital Robert-Debré, AP-HP, 48, boulevard Sérurier, 75935 Paris Cedex 19. jean-navarro@rdb.ap-hop-paris.fr
Insights
Neonatal screening for cystic fibrosis (CF) is now a national priority in France. Early detection through blood trypsin and CF mutation analysis offers significant clinical benefits for affected infants.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Context:
- National medical authorities in France have mandated neonatal screening for cystic fibrosis (CF).
- This decision follows a joint investigation by the French association ADPHE and the national health insurance fund.
- Advancements in therapeutic strategies underscore the need for early CF detection.
Purpose:
- To implement a national neonatal screening program for cystic fibrosis.
- To evaluate the efficacy of a screening method involving immunoreactive trypsin determination followed by CF mutation analysis.
- To improve clinical outcomes for infants diagnosed with cystic fibrosis.
Summary:
- The proposed screening protocol involves measuring blood immunoreactive trypsin levels in newborns.
- Infants with elevated trypsin levels will undergo further testing for common cystic fibrosis (CF) gene mutations.
- This two-tiered approach aims to accurately identify infants with CF.
Impact:
- Effective CF detection through this screening method is anticipated.
- Early diagnosis is expected to lead to substantial clinical benefits for patients.
- The program aims to improve the long-term health and quality of life for individuals with CF.
Abstract:
Neonatal screening for cystic fibrosis was decided by the national medical authorities after a common investigation conducted by the French association ADPHE and national health insurance fund. Based on therapeutic progress and the proposed method using determination of blood immunoreactive trypsin then study of the main CF mutations, there is strong hope of effective CF detection and clinical benefit for the patients.